2011 annual financial data

GT Biopharma 2011 Financial results

Direct answer

Revenue was 26,000 USD.

Operating income was -3,928,000 USD and net income was -3,700,000 USD.
Operating cash flow was -963,000 USD.

Get free GT Biopharma email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
26,000 USD
Operating income
-3,928,000 USD
Net income
-3,700,000 USD
Operating cash flow
-963,000 USD